Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 23, 2022Frontiers in OncologyOpen Access

Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132

View Full Paper
Ask AI
Bookmark
Share

Authors

YCYezhe ChengXYXiaoxi YuanQTQiang Tian

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cheng et al. (2022) studied this question.

synapsesocial.com/papers/6a082634280cd4e998e8a9f9https://doi.org/10.3389/fonc.2022.951589
View Full Paper
Ask AI
Bookmark
Share